Global pharma major Pfizer has said it will have differential pricing on its COVID-19 vaccine for different countries, as the company aims to make the vaccine available across the world. The company's Indian arm has sought emergency use authorisation for the Pfizer/BioNTech vaccine against COVID-19 in the country from the Indian drug regulator. After the UK approval for the vaccine, …
